drugset

drugset / Trial / NCT07196410

KAN-004 for Immune-Related Diarrhea or Colitis

NCT07196410 ↗

Phase 1 Recruiting 21 enrolled University of Montreal Hospital Centre (CHUM)

NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to evaluate the safety and tolerability of KAN-004 in patients with immune-related colitis.

Timeline

Start: 2026-03-01
Primary completion: 2028-12-31
Completion: 2030-12-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	KAN-004	Unknown	—	Oral

Indications